Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa

Virology Journal

Volumn 8, Issue , 2011, Pages

  Ali, Ijaz ^a   Siddique, Lubna ^a   Rehman, Latif U ^a   Khan, Najib U ^a   Iqbal, Aqib ^a   Munir, Iqbal ^a   Rashid, Farzana ^b   Khan, Sana U ^c   Attache, Safira ^a   Swati, Zahoor A ^a   Aslam, Mehwish S ^a  

^a THE UNIVERSITY OF AGRICULTURE   (Pakistan)

^b LAHORE COLLEGE FOR WOMEN UNIVERSITY   (Pakistan)

^c KOHAT UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; DENTAL SURGERY; DIALYSIS; FEMALE; HEALTH CARE FACILITY; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POLYMERASE CHAIN REACTION; PREVALENCE; THALASSEMIA; AGED; BLOOD; CHILD; CROSS INFECTION; GENETICS; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; VIROLOGY;

HEPATITIS C VIRUS;

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CROSS INFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PAKISTAN; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; YOUNG ADULT;

EID: 79958145416     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-296     Document Type: Article

References (30)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 362 10.1126/science.2523562 2523562 (Pubitemid 19117877)
2. Diseases; HepatitisC. WHO, http://www.who.int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index3.html Accessed in 2011
3. Primary prevention of hepatocellular carcinoma in developing countries. CP Wild AJ Hall, Mutat Res 2000 462 381 393 10.1016/S1383-5742(00)00027-2 10767647 (Pubitemid 30190243)
4. Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations. RP Perrillo, Herpetology 1990 12 1433 5
5. Confection of hepatitis C virus in patients with chronic hepatitis B infection. S Sato S Fujiyama M Tanaka, J Hepatol 1994 21 159 66 10.1016/S0168-8278(05)80389-7 7527435 (Pubitemid 24270539)
6. Injection practices in the developing world. SA Van A Hardon, World Health Organization 1997 15 43
7. Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. A Mele ME Tosti A Marzolini A Moiraghi P Ragni G Gallo E Balocchini E Santonastasi T Stroffolini, J Viral Hepatitis 2000 7 30 35 10.1046/j.1365-2893.2000.00179.x (Pubitemid 30139849)
8. Hepatitis C virus infection in polytransfused thalassemic children in Pakistan. S Akhtar T Moatter, Indian Pediatr 2004 41 1072 1073 15523144 (Pubitemid 39425332)
9. Hepatitis C virus in Iran: Epidemiology of an emerging infection. SM Alavian P Adibi MR Zali, Arch Iranian Med 2005 8 84 90 (Pubitemid 40613753)
10. Prevalence of active hepatitis C virus infection in district mansehra Pakistan. A Ali H Ahmad A Ali S Khan G Zaidi M Idrees, Virol J Biomed Central 2010 7 334
11. Prevalence of antibody to hepatitis C virus in Pakistani thalassaemics by particle agglutination test utilizing C 200 and C 22-3 viral antigen coated particles. FA Bhatti M Amin M Saleem, J Pak Med Assoc 1995 45 269 71 8714623
12. Prevalence of hepatitis B, C and HIV virus infection among beta thalassaemia major patients. T Shamsi A Ahmad Z Taj, Pak J Med Res 1998 48 87
13. Prevalence of hepatitis C in beta thalassaemic major. H Hamid R Iqbal MH Khan B Iftikhar S Aziz FK Burki J Sethi M Hassan YB Nisar J Krishan, Gomal J of Med Sciences 2008 6 2
14. Prevalence and risk factors for interfamilial transmission of hepatitis C virus in Karachi, Pakistan. S Akhtar T Moatter SI Azam MH Rahbar S Adil, Baillieres Clin Haematol 1998 11 147 49 10.1016/S0950-3536(98)80073-5 10872476
15. Hepatitis C assays: Operational characteristics (Phase I and Phase II) Report 1 & 2. WHO, 2001 WHO/BCT/BTS/01.5
16. Unconfirmed reactive screening tests and their impact on donor management. M Rahman SA Khan Y Lodhi, Pak J Med Sci 2008 24 4 517 9
17. Prevalence of hepatitis B in the blood donors of NW.F.P and FATA regions and the current scenario of HBV infection in Pakistan. UK Najib S Lubna A Ijaz I Aqib M Iqbal R Farzana A Sajid R Fazal AS Zahoor, African Journal of Biotechnology 2010 6162 6166
18. Frequency of hepatitis C in Buner, NWFP. N Muhammad, J Coll Physicians Surg Pak 2005 15 11 4 15670516
19. Prevalence of hepatitis 'B' and 'C' in surgical patients. AT Altaf AG Ansari MS Awan AA Ghumro, Pak j Surgery 2006 22 3
20. Should we do Hepatitis-B and C screening on each patient before surgery. IA Choudhary SA Khan Samiullah, Pak J Med Sci 2005 21 278 280 (Pubitemid 41382693)
21. Comparative Analysis Of risk factors and complications of hepatitis B and C infections at Khyber teaching hospital Peshawar. H Khan Z Hayat RU Rehman M Zarif, Hepatitis monthly 2007 2 83 86
22. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. AJ Mohammed AA Qudah KF Shishi AA Sarayreh LA Quraan, Renal data from the arab world 2009 20 488 492
23. Prevalence of hepatitis C in patients on maintenance haemodialysis. A Gul F Iqbal, J Coll Physicians Surg Pak 2003 13 15 18 12685968 (Pubitemid 36416875)
24. Hepatitis C virus infection in patients on long term hemodialysis. AZ Karim K Shah H Rehman A Daud J Ahmed, Gomal Journal of Medical Sciences 2008 6 1
25. Prevalence of hepatitis C in patients with end-stage renal disease before and during hemodialysis. F Shafiq S Akram N Hashmat, Pak J Gastroenterol 2002 16 17 20
26. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. FH Pujol JG Ponce MG Lema F Capriles M Devesa F Sirit, J din Microbiol 1996 34 1633 6 (Pubitemid 26190387)
27. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. I Kuo S ul-Hasan N Galai DL Thomas T Zafar MA Ahmed SA Strathdee, Harm Reduct J 2006 3 26 10.1186/1477-7517-3-26 16914042
28. Seroprevalences and coinfections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan. M Achakzai M Kassi PM Kasi, Trop Doct 2007 37 43 45 10.1258/004947507779951989 17326891 (Pubitemid 46440343)
29. The natural history of community-acquired hepatitis C in the united states: The sentinel counties chronic non-a, non-b hepatitis study team. MJ Alter HS Margolis K Krawczynski FN Judson A Mares WJ Alexander PY Hu JK Miller MA Gerber RE Sampliner LM Emory D Meeks MJ Beach, The New England journal of medicine 1992 327 1899 1905 10.1056/NEJM199212313272702 1280771 (Pubitemid 23006964)
30. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. S Zamani S Ichikawa B Nassirimanesh M Vazirian K Ichikawa MM Gouya P Afshar MO Kihara SM Ravari M Kihara, Int J Drug Policy 2007 18 359 363 10.1016/j.drugpo.2007.02.007 17854723 (Pubitemid 47374506)